Obesity treatment is central to the care of people with #diabesity, but many experience #weight-based #stigma from HCPs. Carol Wysham Marc Cornier Jay SHUBROOK Dr. Scott Kahan ask: How do you use weight-sensitive language? See tinyurl.com/4unvnnzv for practical tips on patient

According to the 2024 ADA guidelines, preferred glucose-lowering medications for people with #T2D and #obesity are those with high-to-very-high dual glucose and weight loss efficacy1,2 Carol Wysham Marc Cornier Jay SHUBROOK ask: How do you prioritize weight management in your

ADA acknowledges the benefits of both ≥ 5% and > 10% weight loss in people with T2D1,2 Carol Wysham Marc Cornier Jay SHUBROOK ask: How much weight loss do you aim for in your patients with T2D and obesity? #obesity #T2D #weightloss

In absence of #diabetes, weekly sc semaglutide 2.4 mg has demonstrated superiority vs placebo in lowering #CV risk associated with overweight and #obesity1 Carol Wysham Marc Cornier Jay SHUBROOK ask: How will data on CV outcome benefits of semaglutide 2.4 mg affect patient care in